» Articles » PMID: 36545507

A Review on the Role of MiR-671 in Human Disorders

Overview
Specialty Biology
Date 2022 Dec 22
PMID 36545507
Authors
Affiliations
Soon will be listed here.
Abstract

miR-671 is encoded by a gene on 7q36.1 and contributes to the pathogenesis of a variety of disorders, including diverse types of cancers, atherosclerosis, ischemic stroke, liver fibrosis, osteoarthritis, Parkinson's disease, rheumatoid arthritis, acute myocardial infarction and Crohn's disease. In the context of cancer, different studies have revealed opposite roles for this miRNA. In brief, it has been shown to be down-regulated in pancreatic ductal carcinoma, ovarian cancer, gastric cancer, osteosarcoma, esophageal squamous cell carcinoma and myelodysplastic syndromes. Yet, miR-671 has been up-regulated in glioma, colorectal cancer, prostate cancer and hepatocellular carcinoma. Studies in breast, lung and renal cell carcinoma have reported inconsistent results. The current review aims at summarization of the role of miR-671 in these disorders focusing on its target mRNA in each context and dysregulated signaling pathways. We also provide a summary of the role of this miRNA as a prognostic factor in malignancies.

Citing Articles

miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors.

Nyiro G, Szeredas B, Decmann A, Herold Z, Vekony B, Borka K Cancers (Basel). 2024; 16(14).

PMID: 39061169 PMC: 11275009. DOI: 10.3390/cancers16142528.


Supragingival Bacterium Oral Infection-Induced Periodontitis and Robust miRNA Expression Kinetics.

Aravindraja C, Jeepipalli S, Duncan W, Vekariya K, Rahaman S, Chan E Int J Mol Sci. 2024; 25(11).

PMID: 38892405 PMC: 11172800. DOI: 10.3390/ijms25116217.


Downregulation of lncRNA SATB2‑AS1 facilitates glioma cell proliferation by sponging miR‑671‑5p.

Gu J, Ye Y, Sunil R, Zhan W, Yu R Exp Ther Med. 2023; 26(5):503.

PMID: 37822583 PMC: 10562957. DOI: 10.3892/etm.2023.12202.


Salidroside Ameliorates Ischemia/Reperfusion-Induced Human Cardiomyocyte Injury by Inhibiting the Circ_0097682/miR-671-5p/USP46 Pathway.

Yang Y, Liang F, Gao J, Li J, Jiang C, Xie W Cardiovasc Toxicol. 2023; 23(11-12):406-418.

PMID: 37740139 DOI: 10.1007/s12012-023-09808-3.

References
1.
Kim H, Yang J, Jin Y, Jheon S, Kim K, Lee C . MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status. Oncotarget. 2016; 8(5):8484-8498. PMC: 5352416. DOI: 10.18632/oncotarget.14298. View

2.
Wang W, Yuan Y, Zhang D, Liu P, Liu F . miR-671-5p repressed progression of papillary thyroid carcinoma via TRIM14. Kaohsiung J Med Sci. 2021; 37(11):983-990. DOI: 10.1002/kjm2.12424. View

3.
Wang C, Liu J, Zhang X, Chen Q, Bai X, Hong X . Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury. Front Pharmacol. 2022; 12:784489. PMC: 8801877. DOI: 10.3389/fphar.2021.784489. View

4.
Harrison E, Porrello A, Bowman B, Belanger A, Yacovone G, Azam S . A Circle RNA Regulatory Axis Promotes Lung Squamous Metastasis via CDR1-Mediated Regulation of Golgi Trafficking. Cancer Res. 2020; 80(22):4972-4985. PMC: 7669576. DOI: 10.1158/0008-5472.CAN-20-1162. View

5.
Li Z, Zhang Z, Bi H, Zhang Q, Zhang S, Zhou L . Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer. Mol Med Rep. 2019; 20(4):3149-3159. PMC: 6755202. DOI: 10.3892/mmr.2019.10563. View